A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
Erkan D; Vega J; Ramón G; Kozora E; Lockshin MD; Arthritis And Rheumatism, 2013, vol. 65, issue 2, p 464, ISSN 15290131. ISBN 15290131.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef